Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Defining the pre-leukemic stem cell state through transcriptional and epigenetic interrogation at single cell resolution
FY 2018-19
Summary
Acute myeloid leukemia is a deadly blood cancer with only 1 in 3 patients surviving 3 years beyond diagnosis. Most AML patients are diagnosed only after they present with acute complications of bone marrow failure, highlighting the importance of early detection and intervention. While great strides have been made recently in identifying pre-leukemic stem cells and predicting the risk of AML developing in asymptomatic individuals, we lack a sufficient understanding of the underlying biology of these pre-leukemic stem cells and consequently have no means of intervention to halt AML development. To address this gap, I will work with blood samples collected from AML patients years before their diagnosis and isolate the pre-leukemic stem cells in these samples. I will use single cell sequencing technologies and employ computational methods to identify gene regulatory networks that capture the essence of the pre-leukemic state. I will then examine these networks to identify targets that we can exploit therapeutically in order to eliminate the pre-leukemic stem cells while sparing healthy blood stem cells. The results from this study will inform efforts to understand and target pre-leukemia and bring us closer to introducing early detection and intervention into the clinic towards preventing this devastating disease.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
396626
Name
Zeng Andy G
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Defining the pre-leukemic stem cell state through transcriptional and epigenetic interrogation at single cell resolution
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Leukemia
Abstract
Acute myeloid leukemia is a deadly blood cancer with only 1 in 3 patients surviving 3 years beyond diagnosis. Most AML patients are diagnosed only after they present with acute complications of bone marrow failure, highlighting the importance of early detection and intervention. While great strides have been made recently in identifying pre-leukemic stem cells and predicting the risk of AML developing in asymptomatic individuals, we lack a sufficient understanding of the underlying biology of these pre-leukemic stem cells and consequently have no means of intervention to halt AML development. To address this gap, I will work with blood samples collected from AML patients years before their diagnosis and isolate the pre-leukemic stem cells in these samples. I will use single cell sequencing technologies and employ computational methods to identify gene regulatory networks that capture the essence of the pre-leukemic state. I will then examine these networks to identify targets that we can exploit therapeutically in order to eliminate the pre-leukemic stem cells while sparing healthy blood stem cells. The results from this study will inform efforts to understand and target pre-leukemia and bring us closer to introducing early detection and intervention into the clinic towards preventing this devastating disease.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zeng, Andy G
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~